relacorilant
Showing 1 - 7 of 7
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Cushing Syndrome, Tumors Trial (Dabigatran Etexilate, Relacorilant)
Not yet recruiting
- Cushing Syndrome
- Neoplasms
- Dabigatran Etexilate
- Relacorilant
- (no location specified)
Apr 22, 2022
Healthy Trial in Springfield (Relacorilant, Placebo to relacorilant, Moxifloxacin)
Completed
- Healthy
- Relacorilant
- +2 more
-
Springfield, MissouriSingle Site
Sep 10, 2021
Adrenocortical Carcinoma Trial in United States (Relacorilant, Pembrolizumab)
Recruiting
- Adrenocortical Carcinoma
- Relacorilant
- Pembrolizumab
-
Stanford, California
- +5 more
Jun 27, 2022
Hypercortisolism Trial in Worldwide (relacorilant, Placebo)
Recruiting
- Hypercortisolism
- relacorilant
- Placebo
-
Birmingham, Alabama
- +50 more
Dec 13, 2022
Cushing Syndrome Trial in Worldwide (Relacorilant, Placebo)
Recruiting
- Cushing Syndrome
- Relacorilant
- Placebo
-
Phoenix, Arizona
- +68 more
Nov 14, 2022
Healthy Trial in Tempe (Midazolam HCl, Metoprolol tartrate, Pioglitazone HCl)
Completed
- Healthy
- Midazolam hydrochloride
- +5 more
-
Tempe, ArizonaCelerion
May 16, 2018